nafamostat has been researched along with Colitis Gravis in 4 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
| Excerpt | Relevance | Reference |
|---|---|---|
| "For each of 10 patients with ulcerative colitis, we used four types of anticoagulants sequentially [NM (30-50 mg), heparin, low-molecular-weight heparin (LMWH) and NM (1 mg), and LMWH] for LCAP." | 2.73 | Selection of anticoagulants for leukocytapheresis therapy in cases of active ulcerative colitis. ( Hiraishi, H; Hoshino, M; Kanke, K; Nakano, M; Terano, A; Tominaga, K, 2007) |
| " There were no significant differences in the incidence of adverse reactions (8." | 1.43 | Safety and Tolerability of Nafamostat Mesilate and Heparin as Anticoagulants in Leukocytapheresis for Ulcerative Colitis: Post Hoc Analysis of a Large-Scale, Prospective, Observational Study. ( Hibi, T; Ino, T; Kusada, M; Nakamura, T; Numata, T; Ohdo, M; Sakou, J; Sawada, K; Shibata, H, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sawada, K | 2 |
| Ohdo, M | 1 |
| Ino, T | 1 |
| Nakamura, T | 1 |
| Numata, T | 1 |
| Shibata, H | 1 |
| Sakou, J | 1 |
| Kusada, M | 1 |
| Hibi, T | 1 |
| Ashizuka, S | 1 |
| Nishiura, R | 1 |
| Ishikawa, N | 1 |
| Yamaga, J | 1 |
| Inatsu, H | 1 |
| Fujimoto, S | 1 |
| Eto, T | 1 |
| Kanke, K | 1 |
| Hoshino, M | 1 |
| Tominaga, K | 1 |
| Nakano, M | 1 |
| Terano, A | 1 |
| Hiraishi, H | 1 |
| Nagase, K | 1 |
| Ohnishi, K | 1 |
| Egashira, A | 1 |
| Ohkusu, K | 1 |
| Shimoyama, T | 1 |
1 trial available for nafamostat and Colitis Gravis
| Article | Year |
|---|---|
Selection of anticoagulants for leukocytapheresis therapy in cases of active ulcerative colitis.
Topics: Anticoagulants; Benzamidines; Biocompatible Materials; Biomarkers; Bradykinin; Colitis, Ulcerative; | 2007 |
3 other studies available for nafamostat and Colitis Gravis
| Article | Year |
|---|---|
Safety and Tolerability of Nafamostat Mesilate and Heparin as Anticoagulants in Leukocytapheresis for Ulcerative Colitis: Post Hoc Analysis of a Large-Scale, Prospective, Observational Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Benzamidines; Child; Colitis, Ulcerative | 2016 |
Leukocytapheresis for ulcerative colitis: a comparative study of anticoagulant (nafamostat mesilate vs. dalteparin sodium) for reducing clinical complications.
Topics: Adolescent; Adult; Aged; Anticoagulants; Benzamidines; Colitis, Ulcerative; Dalteparin; Female; Guan | 2006 |
Complications of leukocytapheresis.
Topics: Adult; Anticoagulants; Benzamidines; Colitis, Ulcerative; Crohn Disease; Female; Guanidines; Heparin | 1998 |